Search research articles
Contact Us
Filters
Showing results (11-20 of 150) with videos related to
Page
of 15
Sort By:
Expert Review of Clinical Immunology
|
November 13, 2013
Certolizumab pegol in axial spondyloarthritis
In-Ho Song, Martin Rudwaleit
Expert Review of Clinical Immunology
|
May 19, 2010
Adalimumab for the treatment of psoriatic arthritis
Denis A Poddubnyy, Martin Rudwaleit
Expert Opinion on Pharmacotherapy
|
April 12, 2007
Adalimumab for the treatment of ankylosing spondylitis
Joachim Sieper, Martin Rudwaleit, Jürgen Braun
Best Practice & Research. Clinical Rheumatology
|
September 15, 2023
Challenges in the diagnosis of axial spondyloarthritis
Floris A van Gaalen, Martin Rudwaleit
Rheumatology (Oxford, England)
|
May 18, 2013
Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores
Ernst Feldtkeller, Martin Rudwaleit, Henning Zeidler
Zeitschrift Fur Rheumatologie
|
December 19, 2023
[The role of HLA-B27 in the pathogenesis and diagnosis of axial spondyloarthritis : 50 years after discovery of the strong genetic association]
Jürgen Braun, Martin Rudwaleit, Joachim Sieper
Nature Clinical Practice. Rheumatology
|
October 8, 2008
Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis
Heiner Appel, Martin Rudwaleit, Joachim Sieper
Rheumatology International
|
March 30, 2013
Core set of recommendations for patients with ankylosing spondylitis concerning behaviour and environmental adaptations
Ernst Feldtkeller, Gudrun Lind-Albrecht, Martin Rudwaleit
Current Rheumatology Reports
|
October 5, 2007
Diagnosing early ankylosing spondylitis
In-Ho Song, Joachim Sieper, Martin Rudwaleit
Best Practice & Research. Clinical Rheumatology
|
June 17, 2006
Concepts and epidemiology of spondyloarthritis
Joachim Sieper, Martin Rudwaleit, Muhammed Asim Khan, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 150) with videos related to
Sort By:
Page
of 15
Expert Review of Clinical Immunology
|
November 13, 2013
Certolizumab pegol in axial spondyloarthritis
In-Ho Song, Martin Rudwaleit
Expert Review of Clinical Immunology
|
May 19, 2010
Adalimumab for the treatment of psoriatic arthritis
Denis A Poddubnyy, Martin Rudwaleit
Expert Opinion on Pharmacotherapy
|
April 12, 2007
Adalimumab for the treatment of ankylosing spondylitis
Joachim Sieper, Martin Rudwaleit, Jürgen Braun
Best Practice & Research. Clinical Rheumatology
|
September 15, 2023
Challenges in the diagnosis of axial spondyloarthritis
Floris A van Gaalen, Martin Rudwaleit
Rheumatology (Oxford, England)
|
May 18, 2013
Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores
Ernst Feldtkeller, Martin Rudwaleit, Henning Zeidler
Zeitschrift Fur Rheumatologie
|
December 19, 2023
[The role of HLA-B27 in the pathogenesis and diagnosis of axial spondyloarthritis : 50 years after discovery of the strong genetic association]
Jürgen Braun, Martin Rudwaleit, Joachim Sieper
Nature Clinical Practice. Rheumatology
|
October 8, 2008
Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis
Heiner Appel, Martin Rudwaleit, Joachim Sieper
Rheumatology International
|
March 30, 2013
Core set of recommendations for patients with ankylosing spondylitis concerning behaviour and environmental adaptations
Ernst Feldtkeller, Gudrun Lind-Albrecht, Martin Rudwaleit
Current Rheumatology Reports
|
October 5, 2007
Diagnosing early ankylosing spondylitis
In-Ho Song, Joachim Sieper, Martin Rudwaleit
Best Practice & Research. Clinical Rheumatology
|
June 17, 2006
Concepts and epidemiology of spondyloarthritis
Joachim Sieper, Martin Rudwaleit, Muhammed Asim Khan, et al.
Page
of 15